181 related articles for article (PubMed ID: 19204927)
1. Polymorphisms at p53, p73, and MDM2 loci modulate the risk of tobacco associated leukoplakia and oral cancer.
Misra C; Majumder M; Bajaj S; Ghosh S; Roy B; Roychoudhury S
Mol Carcinog; 2009 Sep; 48(9):790-800. PubMed ID: 19204927
[TBL] [Abstract][Full Text] [Related]
2. Combined effects of the p53 codon 72 and p73 G4C14-to-A4T14 polymorphisms on the risk of HPV16-associated oral cancer in never-smokers.
Chen X; Sturgis EM; El-Naggar AK; Wei Q; Li G
Carcinogenesis; 2008 Nov; 29(11):2120-5. PubMed ID: 18701437
[TBL] [Abstract][Full Text] [Related]
3. Combined effect of genetic polymorphisms in P53, P73, and MDM2 on non-small cell lung cancer survival.
Liu L; Wu C; Wang Y; Zhong R; Duan S; Wei S; Lin S; Zhang X; Tan W; Yu D; Nie S; Miao X; Lin D
J Thorac Oncol; 2011 Nov; 6(11):1793-800. PubMed ID: 21841506
[TBL] [Abstract][Full Text] [Related]
4. Association of p73 and MDM2 polymorphisms with the risk of epithelial ovarian cancer in Chinese women.
Kang S; Wang DJ; Li WS; Wang N; Zhou RM; Sun DL; Duan YN; Li SZ; Li XF; Li Y
Int J Gynecol Cancer; 2009 May; 19(4):572-7. PubMed ID: 19509552
[TBL] [Abstract][Full Text] [Related]
5. p73 G4C14-to-A4T14 gene polymorphism and interaction with p53 exon 4 Arg72Pro on cancer susceptibility: a meta-analysis of the literature.
De Feo E; Simone B; Kamgaing RS; Gallì P; Hamajima N; Hu Z; Li G; Li Y; Matsuo K; Park JY; Roychoudhury S; Spitz MR; Wei Q; Zhang JH; Ricciardi W; Boccia S
Mutagenesis; 2012 May; 27(3):267-73. PubMed ID: 21976716
[TBL] [Abstract][Full Text] [Related]
6. Combined effects of p73 and MDM2 polymorphisms on the risk of lung cancer.
Jun HJ; Park SH; Lee WK; Choi JE; Jang JS; Kim EJ; Cha SI; Kim DS; Kam S; Kim CH; Kang YM; Jung TH; Park JY
Mol Carcinog; 2007 Feb; 46(2):100-5. PubMed ID: 17013834
[TBL] [Abstract][Full Text] [Related]
7. Association of p73 G4C14-A4T14 and p53 codon 72 polymorphism with cervical cancer in Chinese population.
Guo H; Wen Z; Yang S; Qi H
Indian J Cancer; 2022; 59(1):33-38. PubMed ID: 34380847
[TBL] [Abstract][Full Text] [Related]
8. Combined p53-related genetic variants together with HPV infection increase oral cancer risk.
Wang Z; Sturgis EM; Zhang Y; Huang Z; Zhou Q; Wei Q; Li G
Int J Cancer; 2012 Aug; 131(3):E251-8. PubMed ID: 22052649
[TBL] [Abstract][Full Text] [Related]
9. [Association of the responsiveness of advanced non-small cell lung cancer to platinum-based chemotherapy with p53 and p73 polymorphisms].
Yuan P; Miao XP; Zhang XM; Wang ZH; Tan W; Zhang XR; Sun Y; Xu BH; Lin DX
Zhonghua Zhong Liu Za Zhi; 2006 Feb; 28(2):107-10. PubMed ID: 16750013
[TBL] [Abstract][Full Text] [Related]
10. Association study between P53 and P73 gene polymorphisms and the sporadic late-onset form of Alzheimer's disease.
Scacchi R; Gambina G; Moretto G; Corbo RM
J Neural Transm (Vienna); 2009 Sep; 116(9):1179-84. PubMed ID: 19657586
[TBL] [Abstract][Full Text] [Related]
11. Role of functional polymorphisms of P53 and P73 genes with the risk of prostate cancer in a case-control study from Northern India.
Mittal RD; George GP; Mishra J; Mittal T; Kapoor R
Arch Med Res; 2011 Feb; 42(2):122-7. PubMed ID: 21565625
[TBL] [Abstract][Full Text] [Related]
12. Polymorphisms at XPD and XRCC1 DNA repair loci and increased risk of oral leukoplakia and cancer among NAT2 slow acetylators.
Majumder M; Sikdar N; Ghosh S; Roy B
Int J Cancer; 2007 May; 120(10):2148-56. PubMed ID: 17290401
[TBL] [Abstract][Full Text] [Related]
13. Association of a p73 exon 2 G4C14-to-A4T14 polymorphism with risk of hepatocellular carcinoma in a Chinese population.
Deng B; Liu F; Wei Y; Luo L; Chen X; Yan L; Li B
Tumour Biol; 2013 Feb; 34(1):293-9. PubMed ID: 23065572
[TBL] [Abstract][Full Text] [Related]
14. Combined analysis of the association between p73 G4C14-to-A4T14 polymorphisms and cancer risk.
Wang L; Gao R; Yu L
Mol Biol Rep; 2012 Feb; 39(2):1731-8. PubMed ID: 21617940
[TBL] [Abstract][Full Text] [Related]
15. A case-control study on the combined effects of p53 and p73 polymorphisms on head and neck cancer risk in an Italian population.
Gallì P; Cadoni G; Volante M; De Feo E; Amore R; Giorgio A; Arzani D; Paludetti G; Ricciardi G; Boccia S
BMC Cancer; 2009 May; 9():137. PubMed ID: 19426493
[TBL] [Abstract][Full Text] [Related]
16. p73 G4C14-to-A4T14 polymorphism and risk of lung cancer.
Li G; Wang LE; Chamberlain RM; Amos CI; Spitz MR; Wei Q
Cancer Res; 2004 Oct; 64(19):6863-6. PubMed ID: 15466174
[TBL] [Abstract][Full Text] [Related]
17. Role of p53 and p73 genes polymorphisms in susceptibility to esophageal cancer: a case control study in a northern Indian population.
Umar M; Upadhyay R; Khurana R; Kumar S; Ghoshal UC; Mittal B
Mol Biol Rep; 2012 Feb; 39(2):1153-62. PubMed ID: 21573788
[TBL] [Abstract][Full Text] [Related]
18. No association between p73 G4C14-to-A4T14 polymorphism and the risk of lung cancer in a Korean population.
Choi JE; Kang HG; Chae MH; Kim EJ; Lee WK; Cha SI; Kim CH; Jung TH; Park JY
Biochem Genet; 2006 Dec; 44(11-12):543-50. PubMed ID: 17136456
[TBL] [Abstract][Full Text] [Related]
19. [Correlation of p73 polymorphisms to genetic susceptibilities to esophageal carcinoma and gastric cardiac carcinoma].
Ge H; Wang YM; Cao YY; Zhang XF; Li Y; Guo W; Wang N; Zhang JH
Ai Zheng; 2006 Nov; 25(11):1351-5. PubMed ID: 17094900
[TBL] [Abstract][Full Text] [Related]
20. Association of a p73 exon 2 G4C14-to-A4T14 polymorphism with risk of squamous cell carcinoma of the head and neck.
Li G; Sturgis EM; Wang LE; Chamberlain RM; Amos CI; Spitz MR; El-Naggar AK; Hong WK; Wei Q
Carcinogenesis; 2004 Oct; 25(10):1911-6. PubMed ID: 15180941
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
